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Abstract
Lead exposure remains a global public health issue, and the recent Flint water crisis has renewed 
public concern about lead toxicity. The toxicity of lead has been well established in a variety of 
systems and organs. The gut microbiome has been shown to be highly involved in many critical 
physiological processes, including food digestion, immune system development and metabolic 
homeostasis. However, despite the key role of the gut microbiome in human health, the functional 
impact of lead exposure on the gut microbiome has not been studied. The aim of this study is to 
define gut microbiome toxicity induced by lead exposure in C57BL/6 mice using multi-omics 
approaches, including 16S rRNA sequencing, whole genome metagenomics sequencing and gas 
chromatography-mass spectrometry (GC-MS) metabolomics. 16S rRNA sequencing revealed that 
lead exposure altered the gut microbiome trajectory and phylogenetic diversity. Metagenomics 
sequencing and metabolomics profiling showed that numerous metabolic pathways, including 
vitamin E, bile acids, nitrogen metabolism, energy metabolism, oxidative stress and the defense/
detoxification mechanism, were significantly disturbed by lead exposure. These perturbed 
molecules and pathways may have important implications for lead toxicity in the host. Taken 
together, these results demonstrated that lead exposure not only altered gut microbiome 
community structures/diversity but also greatly affected metabolic functions, leading to gut 
microbiome toxicity.
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Introduction
As one of the oldest known and most widely studied metals, lead has been recognized as a 
toxin since antiquity. The primary sources of lead exposure are water, food, soil, paint, 
leaded gasoline, food preparation utensils and electronic waste.1–3 The phasing out of lead 
in gasoline and the restriction of the amount of lead permitted in paint substantially lowered 
the blood lead levels in the U.S. population.4 However, the Flint water crisis has renewed 
public awareness of lead toxicity. After the city’s water source was changed from Lake 
Huron to the Flint River, increases were observed in the lead concentration in Flint’s water 
supply and the blood lead levels in children.5 Children are more susceptible to lead toxicity 
than adults, and cognitive development problems make childhood lead exposure a special 
public health concern.6 In addition to its neurobehavioral toxicity, lead exposure has 
destructive effects on the reproductive, hematopoietic, cardiovascular, gastrointestinal, 
circulatory, immunological and renal systems and deleterious effects on the urinary tract, 
liver and kidney.1, 7–10 Lead causes oxidative stress and impairs the antioxidant defense 
systems.11 Antioxidants, such as herbs, bioactive peptides, vitamin E and N-acetylcysteine, 
have been demonstrated to protect against lead toxicity.12, 13
The gut microbiome, which is also known as our “second genome”, has received much 
attention recently due to its involvement in human health and disease.14 The gut microbiome 
plays a key role in gut permeability and inflammation, energy harvest and lipid 
metabolism.15, 16 Disruption or dysbiosis of gut bacteria is associated with diverse diseases, 
such as allergies, gastric cancer, autism, obesity, anorexia, Crohn’s disease, inflammatory 
bowel disease and diabetes.17 Host-microbiome metabolic interactions can trigger biological 
effects both locally and systemically.18 For example, the gut microbiome produces short-
chain fatty acids (acetate, propionate and butyrate), vitamins and other cofactors through the 
digestion of polysaccharides.19 The gut microbiome also produces metabolites through 
amino acid fermentation, such as cresol and indole, which can be toxic to the host.20 
Likewise, the gut microbiome biotransforms primary hydrophilic bile acids to secondary 
hydrophobic bile acids in the large intestine via deconjugation, oxidation, epimerization and 
dihydroxylation.21 Bile acids can facilitate fat and fat-soluble vitamin absorption and 
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maintain cholesterol homeostasis.22 Furthermore, bile acids are viewed as signaling 
molecules that bind to nuclear receptor FXR and the G-protein-coupled receptor TGR5.21, 23
The gut microbiome can be affected by many factors, including genetics, gender, age and 
antibiotics. Recent studies showed that the gut microbiome was disturbed by heavy metals, 
such as arsenic, cadmium and lead.24–27 A previous study investigated the impact of eight 
weeks of oral lead ingestion at a 100 or 500 ppm concentration on the gut bacterial 
compositions of mice via pyrosequencing of the 16S rRNA gene.28 However, the functional 
effects of lead on the gut microbiome remain unknown. Functional characterization of gut 
microbiome changes is clearly more important and informative than bacterial composition 
profiling by itself. Therefore, in the present study, we applied 16S rRNA sequencing, whole 
genome metagenomics sequencing and gas chromatography-mass spectrometry (GC-MS) 
metabolomics profiling to explore the effects of lead exposure on the gut microbiome and its 
functions and to define gut microbiome toxicity. The 16S rRNA sequencing provided the 
phylogenetic and taxonomic information needed to infer the microbial community 
structures. Whole genome metagenomics sequencing not only identifies the abundance and 
diversity of the microbial community but also reveals the gene contents and functional 
potential of genes encoded in the whole genomes of the microbial community.29 This 
approach can be coupled with metabolomic profiling to better understand the impact of lead 
exposure on the metabolic functions of the gut microbiome. Taken together, these system-
level approaches reveal that lead exposure has a profound effect on gut microbiome 
development and numerous key metabolites and metabolic/cellular pathways of gut bacteria, 
leading to gut microbiome toxicity.
Materials and Methods
Animals and exposure
Specific pathogen-free C57BL/6 female mice (~7 weeks old) were purchased from Jackson 
Laboratory and housed at the University of Georgia animal facility for one week before the 
experiment. The mice were allowed to consume tap water ad libitum. Before and throughout 
the experimental period, the mice were housed under environmental conditions of 22°C, 40–
70% humidity and a 12:12 hr light:dark cycle and were provided a standard rodent pellet 
diet. At the start of experimentation, the mice were randomly assigned to either a control or 
a lead-treated group (n=5). Lead chloride (Sigma-Aldrich, catalog number 449865) was 
administered to the mice in their drinking water at a concentration of 10 ppm (based on the 
lead content) for a study period of 13 weeks. This concentration was equivalent to ~2 mg/kg 
body weight/day. The control mice received water alone. The animal protocol was approved 
by the University of Georgia Institutional Animal Care and Use Committee. The animals 
were treated humanely with attention to the alleviation of their suffering.
16S rRNA gene sequencing
16S rRNA gene sequencing was performed as previously described using fecal pellets 
collected before exposure (day 0) and 4 weeks (week 4) and 13 weeks post-exposure (week 
13).27 Briefly, total DNA was extracted from the fecal pellets collected during necropsy 
using the PowerSoil® DNA Isolation Kit according to the manufacturer’s instructions. For 
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16S rRNA gene sequencing, DNA was amplified using the 515F and 806R primers,30 which 
target the V4 region of the 16S rRNA gene, followed by normalization and barcoding. The 
resulting DNA was pooled, quantified using the Qubit 2.0 Fluorometer and sequenced at the 
Georgia Genomics Facility using an Illumina MiSeq (500 cycles v2 kit). Operational 
taxonomic unit (OTU) picking and the diversity analysis were performed with the 
Quantitative Insights into Microbial Ecology (QIIME) software package.
Metagenomics sequencing
DNA (10 ng/μL) was fragmented using the Bioruptor UCD-300 sonication device, followed 
by sequencing library construction using the KAPA Hyper Prep Kit according to the 
manufacturer’s instructions. The resulting DNA was pooled, quantified and sequenced at the 
Georgia Genomics Facility using an Illumina NextSeq High Output Flow Cell. Raw FASTQ 
files were imported into the MG-RAST metagenomics analysis server (version 3.5). The 
sequences were assigned to the M5NR Subsystems database for functional analysis with a 
maximum e-value cutoff of 10−5, a 75% minimum identity cutoff and a minimum alignment 
length cutoff of 35. Notably, metagenomics reveals changes only at the gene level and not at 
the protein level. The relative abundance of specific genes was determined by the MG-RAST 
pipeline with multiple steps to address inter-sample variability, including normalization 
using DEseq, log 2 transformation and scaling (0–1).
Metabolomics analysis
Metabolites were isolated using the previously described method with modifications27. 
Briefly, two fecal pellets (~20 mg) were vortexed with 1 mL of methanol/chloroform/water 
solution (2:2:1) for 20 minutes, followed by centrifugation at 1,000 x g for 15 minutes. The 
resulting upper and lower phases were transferred to a flat-bottomed high-performance 
liquid chromatography (HPLC) vials and dried for 4 hours in a SpeedVac, followed by 
derivatization with methoxyamine-HCl and N,O-bis(trimethylsilyl)trifluoroacetamide 
(BSTFA). Then, the samples were injected into an Agilent GC-MS that was running in full 
scan mode. XCMS was used for peak-picking, alignment and extraction of the peak 
intensities. Molecular features with significant changes (p<0.05 and fold change >1.5) were 
identified using the National Institute of Standards and Technology (NIST) Standard 
Reference Database and searched against the Human Metabolome Database to obtain 
function and pathway information.
Statistical analysis
Differences in the gut microbiome composition were analyzed using a nonparametric test in 
the Metastats software as previously described.31 Principle coordinate analysis (PCoA) was 
used to compare gut microbiome profiles between the control and treated samples and 
examine differences in beta diversity based on the UniFrac distance metric.32 Alpha 
diversity was also analyzed to examine the species richness in given samples. A two-tailed 
Welch’s t-test was used to initially profile individual metabolite differences between the 
control and treatment groups (p<0.05), as described elsewhere.27, 33 Partial least squares 
discriminant analysis (PLS-DA) was used to compare the metabolomics profiles between the 
control and lead-treated groups.
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Results
Lead exposure disrupted gut microbiome trajectories
First, we used 16S rRNA gene sequencing to examine changes in the gut bacterial 
compositions over time using beta and alpha diversity metrics. Beta diversity evaluates the 
diversity in a microbial community between samples, whereas alpha diversity reflects the 
species richness in given samples. One of the key features of the gut microbiome is that it is 
a highly dynamic system, with the gut microbiome composition or abundance changing over 
time (Figure S1). A 3D PCoA plot (Figure 1A) showed that the trajectories of the gut 
microbiome community structures at the genus level were readily differentiated between the 
control and lead-treated mice. At day 0, the gut microbiome community structures were 
similar for all animals at baseline. Conversely, the microbial community structures were 
significantly different between the control and lead-treated animals at weeks 4 and 13. The 
different trajectories between the control and treated animals indicated a strong effect of lead 
on disrupting gut microbiome development. Consistently, the phylogenetic diversity or 
species richness of the control animals increased over time based on the phylogenetic 
diversity (PD) whole tree, which is an alpha diversity metric (Figure 1B). However, the 
alpha diversity increased to a much lesser extent in the lead-treated mice than in the control 
animals. The alpha diversity of the lead-treated animals at week 13 was equivalent to that of 
the control mice at week 4. These dynamic changes in alpha diversity demonstrated that 
disruption of the gut microbiome had already occurred at week 4 post-exposure, which was 
the earliest time point assessed. Notably, the alpha diversity was not significantly increased 
at week 4 compared to that at week 0 for the lead-treated animals, indicating that the 
development of phylogenetic diversity was severely inhibited by lead exposure. Figure 2 
illustrated the fold changes of significantly perturbed gut bacterial genera that were induced 
by lead exposure at weeks 4 and 13 compared to the controls (see Tables S1 and S2 for 
individual variations in all bacterial genera). The majority of the altered bacterial genera 
were reduced due to lead exposure.
Lead exposure reduced vitamin E and bile acids in the gut microbiome
Since the gut microbiome plays a key role in metabolic processing, next we used 
metabolomics to examine metabolic changes associated with gut microbiome perturbations. 
Lead exposure perturbed the metabolic profiles of the gut microbiome, leading to the 
identification of 1314 molecular features with p<0.05 and fold changes >1.5. The control 
and lead-treated groups could be readily differentiated using metabolite features (Figure S2), 
and excellent separation of the control and lead-treated animals was achieved using the first 
two components of the PLS-DA. Metabolites with diverse structures were identified (Table 
S3). For example, two forms of vitamin E (α-tocopherol and γ-tocopherol), the primary bile 
acids cholic acid (CA) and ursodeoxycholic acid (UDCA), the secondary bile acid 
deoxycholic acid (DCA) and cholesterol and its derivative coprostanol were significantly 
down-regulated, as shown in Figure 3.
Lead exposure altered the nitrogen metabolism of gut bacteria
Nitrogen metabolism is a key component of the metabolic functions in the gut microbiome. 
We used metagenomics and metabolomics to examine whether lead exposure altered 
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pathways and metabolites related to nitrogen metabolism. As shown in Figure 4A, the lead-
treated group had a higher level of UreE gene than the control group. UreE is an accessory 
protein of urease and plays a key role in urease activation.34, 35 The abundance of gene 
encoding creatinine amidohydrolase was also increased (Figure 4B); this gene is involved in 
nitrogen metabolism by catalyzing creatinine to creatine.36, 37 Urea was significantly 
reduced in the gut bacteria after lead exposure (Figure 4C). Lead exposure also led to a 
significant decrease in hydroxylamine (Figure 4D), which is a precursor of nitrite in 
bacteria. Simultaneously, the gene encoding nitrite reductase [NAD(P)H] (Figure 4E), which 
reduces nitrite to ammonium, decreased, whereas the gene encoding copper-containing 
nitrite reductase, which catalyzes nitrite to nitric oxide, increased (Figure 4F).
Lead exposure altered energy metabolism
The gut microbiome plays a key role in regulating energy metabolism and harvest for the 
host. Therefore, examining the effects of lead on energy metabolism by the gut microbiome 
would be highly informative. The impact of lead exposure on energy metabolism is shown in 
Figure 5. Carbon metabolism was significantly perturbed by lead exposure, with saccharide 
transport being highly activated. The abundance of related genes, including the glucose 
transporter, xylose ABC transporter and hydroxymethyl pyrimidine ABC transporter, was 
increased in the gut bacteria of the lead-treated mice (Figures 5A–C). A key metabolite of 
cellular energy metabolism (glycerol-3-phosphate) was reduced (−2.5-fold, Figure 5D). The 
gene encoding the glycerol-3-phosphate transporter decreased (Figure 5E), whereas the gene 
encoding the acyl-phosphate:glycerol-3-phosphate O-acyltransferase PlsY increased 
following lead exposure; this latter enzyme uses glycerol-3-phosphate as a substrate (Figure 
5F).38 Conversely, the gene encoding deoxyribose-phosphate aldolase increased, as shown in 
Figure 5G; this enzyme can catalyze the lysis of 2-deoxyribose-phosphate to eventually 
produce glycerol-3-phosphate. Two genes encoding pyruvate carboxyl transferase subunit A 
and phosphoenolpyruvate-dihydroxyacetone phosphotransferase, which are involved in 
gluconeogenesis, were down-regulated (Figure 5H and 5I).39, 40 Correspondingly, the carbon 
storage regulator, which negatively regulates gluconeogenesis, was significantly increased 
(Figure 5J). This finding indicates that gluconeogenesis may be inhibited after lead 
exposure.
Lead induced oxidative stress and activated the defense/detoxification mechanism in gut 
bacteria
Lead is known to induce oxidative stress, but whether lead can also cause oxidative stress 
responses in the gut microbiome is unknown. Therefore, we combined metagenomics and 
metabolomics to define the role of lead exposure in oxidative stress and the associated 
detoxification mechanisms in the gut microbiome. Figure 6 shows that lead exposure 
induced oxidative stress and activated the defense mechanism in the gut microbiota. The 
primary toxic effects of lead are due to oxidative stress.41, 42 As shown in Figure 6, the 
abundance levels of several genes involved in resisting oxidative stress were perturbed after 
lead exposure. For instance, the gene encoding coenzyme A disulfide reductase (CoADR) 
was induced by lead exposure (Figure 6A). CoADR is a key gene in redox systems in some 
bacteria that plays a key role in maintaining the reduced state of cells and is involved in the 
robust oxygen defense systems.43, 44 Another related gene (the disulfide-bond regulator) was 
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also increased in the lead-treated animals (Figure 6B). Additionally, MutT was increased in 
the lead-treated mice (Figure 6C); this gene encodes a hydrolase that converts 8-oxodGTP to 
8-oxodGMP and thus is involved in preventing the incorporation of the 8-oxo-Gua lesion 
into the DNA.45, 46 In addition to the induction of DNA damage by oxidative stress, the 
abundance of some genes involved in DNA modification changed after lead exposure. For 
example, the tyrosine recombinase gene XerC was significantly increased in the gut bacteria 
of the lead-treated mice, whereas the gene encoding the type III restriction-modification 
system StyLTI enzyme was reduced (Figures 6D and E).
Defense mechanisms were activated in gut bacteria in response to lead exposure. For 
example, the gene encoding the heavy metal-translocating P-type ATPase, which is involved 
in lead efflux in bacteria, was up-regulated (Figure 6F).47, 48 Likewise, the gene encoding 
the phosphate ABC transporter was significantly increased (Figure 6G), which was 
consistent with the highly reduced phosphoric acid level (Figure 6H). These findings suggest 
that gut bacteria may increase lead precipitation by increasing the extracellular phosphoric 
acid concentration.49, 50
Discussion
We combined 16S rRNA gene sequencing, whole genome metagenomics sequencing and 
metabolomics to study the effects of lead exposure on the gut microbiome and its metabolic 
functions. We demonstrated that lead exposure changed the gut microbiome taxonomic 
composition and the functional metagenome and metabolic profiles in C57BL/6 mice. These 
results highlighted the functional impact of lead exposure on the gut microbiome. Moreover, 
lead perturbed the trajectories of the gut microbiome over time and significantly reduced or 
inhibited the normal development of gut bacterial phylogenetic diversity. Additionally, we 
identified a number of important perturbed metabolites and metabolic pathways. These 
metabolic and cellular signaling pathways include bile acids, vitamins, nitrogen metabolism, 
oxidative stress and defense mechanisms and energy metabolism, which may have important 
implications for lead-induced diseases.
We clearly demonstrated that lead exposure altered gut microbiome community structures. 
In particular, lead interfered with the normal development of gut bacteria over time. We 
showed that lead exposure decreased or inhibited the establishment of normal phylogenetic 
diversity in the gut microbiome, as illustrated in Figure 2, which was an extremely important 
observation. The establishment and development of the gut microbiome is a temporal and 
sensitive process in children. Having a normal gut microbiome is critical for many 
physiological processes, including immune system development, metabolic processing, 
energy production, food digestion and epithelial homeostasis. Lead exposure in children is 
common, and children were found to have increased blood lead levels in the recent Flint 
water crisis. Thus, lead could significantly impact gut microbiome development in children, 
which may contribute to many lead-induced diseases in later life. Clearly, further study is 
warranted to shed light on this possibility.
We found that the abundance of both primary and secondary bile acids was significantly 
reduced by lead exposure (Figure 3). The gut microbiome can transform primary hydrophilic 
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bile acids into secondary hydrophilic bile acids in the large intestine through deconjugation, 
dehydroxylation and dehydrogenation.51 Here, we observed that the secondary bile acid 
DCA was decreased by 2.9-fold in the lead-treated mice relative to that in the control mice. 
DCA is biochemically synthesized from the primary bile acid CA, which was reduced 3.9-
fold in the lead-treated mice compared to that in the controls (Figure 3C). Clearly, bile acid 
homeostasis is significantly altered by lead exposure, which may affect many other 
biological processes due to the key roles of bile acids. As signaling molecules, bile acids 
bind or activate host nuclear receptors to regulate a number of downstream signaling 
pathways.20 Bile acids exert both hepatic and extra-hepatic effects ranging from regulating 
their own biosynthesis to lipid, cholesterol, glucose, lipoprotein, and energy metabolism, 
local gut mucosal defenses and inflammatory responses.23, 52 Primary bile acids are formed 
from cholesterol by multiple enzymes through the modification of the sterol ring and 
oxidation and shortening of the side chains.53 In turn, the formation of bile acids maintains 
cholesterol homeostasis.54 Here, we observed that cholesterol was decreased by 4.5-fold in 
the lead-treated mice (Figure 3F). In addition to cholesterol reduction, we also observed that 
the cholesterol derivative coprostanol was decreased in a corresponding manner (Figure 3E). 
A previous study identified specific gut bacteria associated with fecal cholesterol and 
coprostanol using integrated metabolomics and microbiome analyses.55 Specifically, a total 
of 63 gut microbes were identified, including a number of Ruminococcus and 
Lachnospiraceae species.55 In the present study, we found that Ruminococcus and several 
Lachnospiraceae genera were significantly reduced (Figure 2). Thus, lead exposure greatly 
affected the gut bacterial genera that are highly involved in regulating the homeostasis of 
cholesterol and its derivatives.
Vitamin E is part of a family of eight essential fat-soluble nutrients. Four of the compounds 
carry a tocol structure, and the other four carry a tocotrienol structure.56 A reduction in two 
forms of vitamin E was observed in the lead-treated mice compared with the levels in the 
control mice. The α-tocopherol and γ-tocopherol levels were decreased by 2.8 and 2.2-fold, 
respectively. Vitamin E exhibits both antioxidant and non-antioxidant activities, such as gene 
expression modulation, cell proliferation, platelet aggregation and bone mass regulation.57 
Vitamin E absorption can be affected by many factors, including gut permeability, dietary fat 
availability and a bile salt-dependent carboxyl ester hydrolase.56, 58, 59 Since the gut 
microbiome affects gut permeability,60 lipid metabolism61 and the bile acid pool,52 the 
disturbance of the gut microbiome by lead may affect vitamin E homeostasis. Perturbed bile 
acid pools in lead-treated mice may be attributed to alterations in bile salt-dependent 
enzymatic hydrolysis for vitamin E. Consequently, the absorption of vitamin E could be 
disrupted. Consistent with our results, a previous study showed that the monocolonization of 
germ-free mice affected vitamin E metabolism.62 Likewise, previous studies showed that 
vitamin E could protect cells against lead-induced oxidative stress;2, 13 thus, the reduction in 
vitamin E may also reflect oxidative stress in the gut bacteria arising from lead exposure. 
Interestingly, a few previous human studies found an inverse relationship between the 
vitamin E level and the lead concentration in the blood.63–65 Here, we found reduced 
vitamin E levels in the gut microbiome in the lead-exposed animals, suggesting a potential 
link between vitamin E in the gut microbiome and host tissues. Future studies are needed to 
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elucidate the role of the gut microbiome in the lead-perturbed homeostasis of vitamin E in 
host tissues.
In mammals, nitric oxide (NO) is involved in various physiological and pathophysiological 
events in multiple organs, including the gastrointestinal tract.66, 67 Endogenous NO in the 
gut regulates the mucosal blood flow, mucus generation, gut motility and host defense 
responses.66 Recent studies have revealed that gut bacteria can also generate NO and may 
play an important role in gut physiology.68 As shown in Figure 4, we found that the gene 
encoding copper-containing nitrite reductase, which catalyzes the conversion of nitrite to 
NO, increased after lead exposure. Conversely, we observed decreased abundance of the 
nitrite reductase [NAD(P)H] gene, which is involved in an alternative nitrite metabolism 
pathway. These results may indicate that lead exposure increases NO generation in the gut 
bacteria.
The energy metabolism of the gut bacteria was also dramatically perturbed by lead exposure. 
Our data revealed that genes related to saccharide absorption were highly activated, which 
should increase the energy levels in the gut bacteria. However, other genes, such as 
laminarinase, cyclomaltodextrin glucanotransferase, 5-deoxy-glucuronate isomerase, D-
malate dehydrogenase and glycerol-3-phosphate transporter, were decreased by lead 
treatment. These genes generally promote the degradation of saccharides. In addition, the 
glycerol-3-phosphate level was reduced. Two gluconeogenesis-related genes (pyruvate 
carboxyl transferase subunit A and phosphoenolpyruvate-dihydroxyacetone 
phosphotransferase) were decreased after lead exposure, which was consistent with the up-
regulation of the carbon storage regulator gene that suppressed gluconeogenesis, glycogen 
biosynthesis and catabolism and activated glycolysis and acetate metabolism.69, 70 Taken 
together, these data show that lead exposure disturbs energy production and causes energy 
starvation in gut bacteria, although the specific perturbed steps of glycolysis or respiration 
are unknown. The significant decrease in fatty acids, hexadecanoic acid and linoleic acid in 
lead-treated gut bacteria (Table S3) also partially supports the finding of an energy-deprived 
condition in the gut bacteria.
Lead is known to induce oxidative stress in different systems.41, 42 Lead can generate 
reactive oxygen species to cause damage in cells.41 Two primary redox systems are widely 
adopted by bacteria for protection from oxidative stress: the glutathione thiol/disulfide redox 
system and the reduced CoA thiol/disulfide redox system.42, 43 Glutathione reductase (GSR) 
and coenzyme A disulfide reductase (CoADR) are the key enzymes of each redox system, 
respectively. Coenzyme A disulfide reductase (CoADR) is a key enzyme in an alternative 
redox system in some bacteria that do not contain the glutathione thiol/disulfide redox 
system; this system plays an important role in maintaining the reduced state of cells and is 
involved in robust oxygen defense systems.43, 44 Although we did not observe changes in 
GSR gene abundance, the up-regulation of the CoADR and disulfide-bond regulator genes 
supports the hypothesis that lead induces oxidative stress in gut bacteria. Likewise, the 
increased gene abundance of MutT, which is an oxidative DNA damage repair gene, 
suggests lead-induced oxidative stress. The consequences of lead-induced oxidative stress in 
gut bacteria are not well understood yet.
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As a ubiquitous environmental toxicant, lead can cause severe cellular dysfunction in 
animals, plants and bacteria.71 Bacteria have evolved several mechanisms to resist lead, 
including adsorption by extracellular polysaccharides, precipitation as insoluble phosphates, 
and efflux to the cell exterior via metal-resistant ion channels.50 The gene encoding the 
heavy metal-translocating P-type ATPase significantly increased in the gut bacteria under 
lead exposure. The increased gene abundance of the phosphate ABC transporter gene and 
the greatly reduced phosphoric acid level indicated that gut bacteria might also resist lead by 
sequestering it in the form of phosphate salts, as shown in Figure 6. The activation of lead 
resistance mechanisms suggests an essential role for the gut microbiota in protecting the host 
from lead exposure.
An increase in multiple amino acids was evident in the lead-treated gut bacteria. Amino 
acids that increased after lead exposure included glycine, threonine, serine, glutamate, 
isoleucine, valine and proline. Only alanine was decreased. The metagenomics analysis 
revealed that a series of genes related to amino acid degradation and synthesis were altered 
by lead exposure. The abundance of genes encoding asparagine synthetase, glycine/
sarcosine/betaine reductase protein A, pyruvate carboxyl transferase subunit A, putrescine 
carbamoyltransferase and ornithine aminotransferase was decreased, whereas the abundance 
of the methionine gamma-lyase and aspartate 1-decarboxylase genes was increased in the 
lead-treated group (Figure S3). No simple conclusion could be provided to explain how lead 
influenced the amino acid levels due to the complex regulation of amino acid homeostasis. 
One potential explanation is that lead induces oxidative stress in gut bacteria and increases 
the levels of oxidized proteins, which will largely be degraded by cells and thus increase the 
free amino acid levels.42, 72
In summary, we demonstrated that lead exposure significantly altered the gut microbiome 
trajectories over time, phylogenetic diversity, key metabolites and metabolic and cellular 
signaling pathways. These perturbed molecules and pathways may have important 
implications for lead toxicity in the host and lead-induced diseases. Many issues require 
further study. For example, what is the dose-dependent response to lead exposure, 
particularly at environmental and human-relevant concentrations? What are the health 
effects of lead-induced gut microbiome perturbations in the host? Likewise, what are the 
roles of host responses in mediating the gut microbiome and its functions? Future studies are 
warranted to address these intriguing questions to better understand the complex functional 
interactions among lead, the gut microbiome and the host.
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Abbreviations
GC-MS Gas chromatography-mass spectrometry
PCoA Principle coordinate analysis
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Figure 1. 
Lead exposure disturbed the trajectories of gut microbiome development as assessed by beta 
diversity metrics (A). Lead exposure also reduced/inhibited the phylogenetic diversity of the 
gut bacteria as examined using alpha diversity metrics (B). Here, 16S rRNA gene 
sequencing was performed, followed by bacterial taxonomic assignment via QIIME. Beta 
diversity evaluated the diversity in the microbial community between samples, whereas 
alpha diversity reflected the species richness.
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Figure 2. 
The fold changes of selected significantly changed gut bacterial genera between the controls 
and lead-treated mice (A. 4 weeks post-lead exposure; B. 13 weeks post-lead exposure). The 
fold changes were calculated using the group means for each bacterial genus.
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Figure 3. 
The abundance of key metabolites was measured by GC-MS to examine the impact of lead 
exposure on the metabolic functions of the gut microbiome. Vitamin E, bile acids and 
cholesterol and its derivative were significantly reduced in mice after exposure to lead for 13 
weeks (A. α-tocopherol, B. γ-tocopherol, C. cholic acid, D. deoxycholic acid, E. 
ursodeoxycholic acid; F. cholesterol; and G. coprostanol).
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Figure 4. 
Metagenomics and metabolomics analyses showing that lead exposure significantly alters 
the nitrogen metabolism of the gut bacteria, as evidenced by the perturbed key genes and 
metabolites (A. urease accessory protein UreE; B. creatinine amidohydrolase; C. urea; D. 
hydroxylamine; E. nitrite reductase [NAD(P)H]; and F. copper-containing nitrite reductase). 
N.D.: non-detectable.
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Figure 5. 
Energy metabolism, which is a key metabolic function of the gut microbiome, was disturbed 
by lead exposure, as demonstrated by the altered abundance of a number of bacterial genes 
and the key metabolite glycerol-3-phosphate. N.D.: non-detectable. Note: the relative 
abundance reflects only the gene levels and not the protein levels.
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Figure 6. 
Alterations in key genes and metabolites involved in oxidative stress and the defense 
response indicate that lead exposure activates cellular defense genes (A and B), DNA repair 
systems (C, D and E), and detoxification pathways (F, G and H).
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